In Vitro Diagnostics And IVD Quality Control Industry Data Book - In Vitro Diagnostics & IVD Quality Control Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 - 2030
- Published Date: Sep, 2022
- Report ID: sector-report-00104
- Format: Electronic (PDF)
- Number of Pages: 260
Chapter 1. Methodology and Scope
- 1.1 Market Segmentation
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
- 1.7 Global Market: CAGR Calculation
- 1.8 Research Assumptions
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1
- 1.11.2 Objective 2
- 1.12 List Of Abbreviations
Chapter 2. Market Definitions
- 2.1 Definitions
Chapter 3. Executive Summary
- 3.1 Market Summary
Chapter 4. Global IVD Market and IVD Quality Control Variables, Trends, & Scope
- 4.1 IVD Market Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.2 Penetration And Growth Prospect Mapping
- 4.3 Regulatory Framework
- 4.4 Market Driver Analysis
- 4.4.1 Growing Geriatric Population
- 4.4.2 Technological Advancements
- 4.4.3 Increasing Demand For Poc Facilities
- 4.4.4 Growing Prevalence Of Target Diseases, And Hospital-Acquired Infections
- 4.4.5 Outbreak Of Covid-19
- 4.5 Market Restraint Analysis
- 4.5.1 Higher Cost Of Devices
- 4.5.2 Stringent Regulatory Policies
- 4.6 Value Chain Analysis
- 4.6.1 Value Chain Analysis/Route To Market
- 4.7 Consumer Behavior Analysis
- 4.8 Major Deals and Strategic Alliances Analysis
- 4.8.1 New product launch
- 4.8.1.1 Mergers and acquisitions
- 4.8.1.2 Expansion
- 4.8.1.3 Partnerships
- 4.8.1.4 Marketing & promotions
- 4.8.1.5 Market entry strategies
- 4.8.2 Mergers And Deals
- 4.9 IVD Market Analysis Tools
- 4.9.1 Industry Analysis – Porter’s
- 4.9.2 SWOT Analysis, By Pest
- 4.10 IVD Quality Control Market Analysis Tools
- 4.10.1 Industry Analysis – Porter’s
- 4.10.2 SWOT Analysis, By Pest
Chapter 5. IVD Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 5.1 In Vitro Diagnostic Market: Products Movement Analysis
- 5.2 Instruments
- 5.2.1 Instruments Market, 2018 – 2030, (USD Million, Instruments Installed In Thousands)
- 5.3 Reagents
- 5.3.1 Reagents Market, 2018 – 2030, (USD Million, Reagents Sold In Million)
- 5.4 Services
- 5.4.1 Services Market Estimates And Forecast, 2018 – 2030, (USD Million)
Chapter 6. IVD Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)
- 6.1 In Vitro Diagnostics Market: Technology Movement Analysis
- 6.2 Immunoassay
- 6.2.1 Immunoassay Market, 2018 – 2030, USD Million
- 6.2.2 Instruments
- 6.2.2.1 Instruments For Immunoassay, 2018 – 2030, (USD Million, Instruments Installed In Thousands)
- 6.2.3 Reagents
- 6.2.3.1 Reagents For Immunoassay, 2018 – 2030, (USD Million, Reagents Sold In Million)
- 6.3 Hematology
- 6.3.1 Hematology Market, 2018 – 2030, (USD Million)
- 6.3.2 Instruments
- 6.3.2.1 Instruments for hematology, 2018 – 2030, (USD Million, instruments installed in thousands)
- 6.3.3 Reagents
- 6.3.3.1 Reagents for hematology, 2018 – 2030, (USD Million, Number of reagents sold in million)
- 6.4 Clinical Chemistry
- 6.4.1 Clinical Chemistry, 2018 - 2030 (USD Million)
- 6.4.2 Instruments
- 6.4.2.1 Instruments For Clinical Chemistry, 2018 – 2030, (USD Million, Number Of Instruments Installed In Thousands)
- 6.4.3 Reagents
- 6.4.3.1 Reagents For Clinical Chemistry, 2018 – 2030, (USD Million, Number Of Reagents Sold In Million
- 6.5 Molecular Diagnostics
- 6.5.1 Molecular Diagnostics Market, 2018 – 2030, (USD Million)
- 6.5.2 Instruments
- 6.5.2.1 Instruments For Molecular Diagnostics, 2018 – 2030, (USD Million, Instruments Installed In Thousands)
- 6.5.3 Reagents
- 6.5.3.1 Reagents For Molecular Diagnostics, 2018 – 2030, (USD Million, Reagents Sold In Million)
- 6.6 Coagulation
- 6.6.1 Coagulation Market, 2018 – 2030, (USD Million)
- 6.6.2 Instruments
- 6.6.2.1 Instruments For Coagulation, 2018 – 2030, (USD Million, Number Of Instruments Installed In Thousands)
- 6.6.3 Reagents
- 6.6.3.1 Reagents For Coagulation, 2018 – 2030, (USD Million, Reagents Sold In Million)
- 6.7 Microbiology
- 6.7.1 Microbiology Market, 2018 - 2030 USD Million
- 6.7.2 Instruments
- 6.7.2.1 Instruments For Microbiology, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
- 6.7.3 Reagents
- 6.7.3.1 Reagents For Microbiology, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
- 6.8 Others
- 6.8.1 Others Market Estimates And Forecast, 2018 - 2030 USD Million
- 6.8.2 Instruments
- 6.8.2.1 Instruments for others, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
- 6.8.3 Reagents
- 6.8.3.1 Reagents for others, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
Chapter 7. IVD Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 7.1 In Vitro Diagnostic Market: Application Movement Analysis
- 7.2 Infectious Diseases
- 7.2.1 Infectious Diseases Market, 2018 - 2030 USD Million
- 7.3 Diabetes
- 7.3.1 Diabetes Market, 2018 - 2030 USD Million
- 7.4 Oncology
- 7.4.1 Oncology Market, 2018 - 2030 USD Million
- 7.5 Cardiology
- 7.5.1 Cardiology Market, 2018 - 2030 USD Million
- 7.6 Nephrology
- 7.6.1 Nephrology Market, 2018 - 2030 USD Million
- 7.7 Autoimmune Diseases
- 7.7.1 Autoimmune Diseases Market, 2018 - 2030 USD Million
- 7.8 Drug Testing
- 7.8.1 Drug Testing Market, 2018 - 2030 USD Million
- 7.9 Others
- 7.9.1 Others Market, 2018 - 2030 USD Million
Chapter 8. IVD Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)
- 8.1 In Vitro Diagnostic Market: End-use Movement Analysis
- 8.2 Hospitals
- 8.2.1 Hospitals Market, 2018 - 2030 USD Million
- 8.3 Laboratory
- 8.3.1 Laboratory Market, 2018 - 2030 USD Million
- 8.4 Home Care
- 8.4.1 Home Care Market, 2018 - 2030 USD Million
- 8.5 Others
- 8.5.1 Other Market, 2018 - 2030 USD Million
Chapter 9. IVD Market - Segment Analysis, by Test Location, 2018 - 2030 (USD Million)
- 9.1 In Vitro Diagnostic Market: Test Location Movement Analysis
- 9.2 Point Of Care
- 9.2.1 Point-Of-Care Market, 2018 - 2030 USD Million
- 9.3 Homecare
- 9.3.1 Homecare Market, 2018 - 2030 USD Million
- 9.4 Others
- 9.4.1 Others Market, 2018 - 2030 USD Million
Chapter 10. IVD Quality Control Market - Segment Analysis, by Services, 2018 - 2030 (USD Million)
- 10.1 In Vitro Quality Control Market: Services Movement Analysis
- 10.2 Quality Control
- 10.2.1 Quality control Market, 2018 - 2030 USD Million
- 10.2.2 Clinical Chemistry Market, 2018 - 2030 USD Million
- 10.2.3 Immunochemistry Market, 2018 - 2030 USD Million
- 10.2.4 Hematology Market, 2018 - 2030 USD Million
- 10.2.5 Molecular Diagnostics Market, 2018 - 2030 USD Million
- 10.2.6 Coagulation Market, 2018 - 2030 USD Million
- 10.2.7 Others Market, 2018 - 2030 USD Million
- 10.3 Quality Assurance
- 10.3.1 Quality Assurance Market, 2018 - 2030 USD Million
- 10.3.2 Clinical Chemistry Market, 2018 - 2030 USD Million
- 10.3.3 Immunochemistry Market, 2018 - 2030 USD Million
- 10.3.4 Hematology Market, 2018 - 2030 USD Million
- 10.3.5 Molecular Diagnostics Market, 2018 - 2030 USD Million
- 10.3.6 Coagulation Market, 2018 - 2030 USD Million
- 10.3.7 Others Market, 2018 - 2030 USD Million
- 10.4 Data Management
- 10.4.1 Data Management Market, 2018 - 2030 USD Million
- 10.4.2 Clinical Chemistry Market, 2018 - 2030 USD Million
- 10.4.3 Immunochemistry Market, 2018 - 2030 USD Million
- 10.4.4 Hematology Market, 2018 - 2030 USD Million
- 10.4.5 Molecular Diagnostics Market, 2018 - 2030 USD Million
- 10.4.6 Coagulation Market, 2018 - 2030 USD Million
- 10.4.7 Others Market, 2018 - 2030 USD Million
Chapter 11. IVD and IVD Quality Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
- 11.1 In Vitro Diagnostic and IVD Quality Control Market: Regional Movement Analysis
- 11.2 North America
- 11.2.1 North America, Swot Analysis
- 11.2.2 North America IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.2.3 U.S.
- 11.2.3.1 U.S. IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.2.4 Canada
- 11.2.4.1 Canada IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.3 Europe
- 11.3.1 Europe, Swot Analysis
- 11.3.2 Europe IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.3.3 U.K.
- 11.3.3.1 U.K. IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.3.4 Germany
- 11.3.4.1 Germany IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.3.5 Spain
- 11.3.5.1 Spain IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.3.6 France
- 11.3.6.1 France IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.3.7 Italy
- 11.3.7.1 Italy IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.3.8 Russia
- 11.3.8.1 Russia IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.4 Asia Pacific
- 11.4.1 Asia Pacific, Swot Analysis
- 11.4.2 Asia Pacific IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.4.3 Japan
- 11.4.3.1 Japan IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.4.4 China
- 11.4.4.1 China IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.4.5 INDIA
- 11.4.5.1 India IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.4.6 South Korea
- 11.4.6.1 South Korea IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.4.7 Singapore
- 11.4.7.1 Singapore IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.4.8 Australia
- 11.4.8.1 Australia IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.5 Latin America
- 11.5.1 Latin America, Swot Analysis
- 11.5.2 Latin America Market IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.5.3 Brazil
- 11.5.3.1 Brazil IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.5.4 Mexico
- 11.5.4.1 Mexico IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.5.5 Argentina
- 11.5.5.1 Argentina IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.6 Middle East and Africa
- 11.6.1 Middle East & Africa, Swot Analysis
- 11.6.2 Middle-East And Africa IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.6.3 South Africa
- 11.6.3.1 South Africa Market IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.6.4 United Arab Emirates
- 11.6.4.1 United Arab IVD & IVD Quality Market, 2018 - 2030 USD Million
- 11.6.5 Saudi Arabia
- 11.6.5.1 Saudi Arabia IVD & IVD Quality Market, 2018 - 2030 USD Million
Chapter 12 Competitive Analysis
- 12.1 Recent Developments & Impact Analysis, By Key Market Participants
- 12.1.1 Ansoff Matrix
- 12.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
- 12.1.3 Innovators
- 12.2 Vendor Landscape
- 12.2.1 List Of Key Distributors And Channel Partners
- 12.2.2 Global IVD Market: Key Company Market Share Analysis, 2021
- 12.3 Mass Spectrometry
- 12.3.1 Global Clinical Mass Spectrometry Company Market Share Analysis, 2021
- 12.3.2 North America Clinical Mass Spectrometry Company Market Share Analysis, 2021
- 12.3.3 Europe Clinical Mass Spectrometry Company Market Share Analysis, 2021
- 12.3.4 Asia Pacific Clinical Mass Spectrometry Company Market Share Analysis, 2021
- 12.4 Immunoassay
- 12.4.1 Global Clinical Immunoassay Company Market Share Analysis, 2021
- 12.4.2 North America Clinical Immunoassay Company Market Share Analysis, 2021
- 12.4.3 Europe Clinical Immunoassay Company Market Share Analysis, 2021
- 12.4.4 Asia Pacific Clinical Immunoassay Company Market Share Analysis, 2021
- 12.5 PCR
- 12.5.1 Global Clinical PCR Company Market Share Analysis, 2021
- 12.5.2 North America Clinical PCR Company Market Share Analysis, 2021
- 12.5.3 Europe Clinical PCR Company Market Share Analysis, 2021
- 12.5.4 Asia Pacific Clinical PCR Company Market Share Analysis, 2020
- 12.6 Public Companies
- 12.6.1 Company Market Position Analysis
- 12.6.2 Competitive Dashboard Analysis
- 12.6.3 Strategic Framework
- 12.7 Private Companies
- 12.7.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
- 12.7.2 Regional Network Map
- 12.8 Company Profiles
- 12.8.1 ABBOTT
- 12.8.1.1 Company Overview
- 12.8.1.2 Alere, Inc.
- 12.8.1.3 Financial Performance
- 12.8.1.4 Product Benchmarking
- 12.8.1.5 Strategic Initiatives
- 12.8.2 BIOMÉRIEUX SA
- 12.8.2.1 Company Overview
- 12.8.2.2 Financial Performance
- 12.8.2.3 Product Benchmarking
- 12.8.2.4 Strategic Initiatives
- 12.8.3 BIO-RAD LABORATORIES, INC.
- 12.8.3.1 Company Overview
- 12.8.3.2 Financial Performance
- 12.8.3.3 Product Benchmarking
- 12.8.3.4 Strategic Initiatives
- 12.8.4 BECTON, DICKINSON AND COMPANY
- 12.8.4.1 Company Overview
- 12.8.4.2 Financial Performance
- 12.8.4.3 Product Benchmarking
- 12.8.4.4 Strategic Initiatives
- 12.8.5 SIEMENS HEALTHINEERS AG
- 12.8.5.1 Company Overview
- 12.8.5.2 Financial Performance
- 12.8.5.3 Product Benchmarking
- 12.8.5.4 Strategic Initiatives
- 12.8.6 QIAGEN
- 12.8.6.1 Company Overview
- 12.8.6.2 Financial Performance
- 12.8.6.3 Product Benchmarking
- 12.8.6.4 Strategic Initiatives
- 12.8.7 QUIDEL CORPORATION
- 12.8.7.1 Company Overview
- 12.8.7.2 Financial Performance
- 12.8.7.3 Product Benchmarking
- 12.8.7.4 Strategic Initiatives
- 12.8.8 F. HOFFMANN-LA ROCHE LTD.
- 12.8.8.1 Company Overview
- 12.8.8.2 Financial Performance
- 12.8.8.3 Product Benchmarking
- 12.8.8.4 Strategic Initiatives
- 12.8.9 SYSMEX CORPORATION
- 12.8.9.1 Company Overview
- 12.8.9.2 Financial Performance
- 12.8.9.3 Product Benchmarking
- 12.8.9.4 Strategic Initiatives
- 12.8.10 CHARLES RIVER LABORATORIES
- 12.8.10.1 Company Overview
- 12.8.10.2 Financial Performance
- 12.8.10.3 Product Benchmarking
- 12.8.10.4 Strategic Initiatives
- 12.8.11 QUEST DIAGNOSTICS
- 12.8.11.1 Company Overview
- 12.8.11.2 Financial Performance
- 12.8.11.3 Product Benchmarking
- 12.8.11.4 Strategic Initiatives
- 12.8.12 AGILENT TECHNOLOGIES, INC.
- 12.8.12.1 Company Overview
- 12.8.12.2 Financial Performance
- 12.8.12.3 Product Benchmarking
- 12.8.12.4 Strategic Initiatives
- 12.8.13 DANAHER CORPORATION
- 12.8.13.1 Company Overview
- 12.8.13.2 Cepheid
- 12.8.13.3 Beckman Coulter
- 12.8.13.4 Leica Biosystems
- 12.8.13.5 Financial Performance
- 12.8.13.6 Product Benchmarking
- 12.8.13.7 Strategic Initiatives
- 12.8.13.8 Strategic Initiatives- Beckman Coulter, Inc.
- 12.8.13.9 Strategic Initiatives- Leica Biosystems
- 12.8.14 Bio-Rad Laboratories, Inc.
- 12.8.14.1 Company Overview
- 12.8.14.2 Financial Performance
- 12.8.14.3 Product Benchmarking
- 12.8.14.4 Strategic Initiatives
- 12.8.15 Thermo Fisher Scientific, Inc.
- 12.8.15.1 Company Overview
- 12.8.15.2 Financial Performance
- 12.8.15.3 Product Benchmarking
- 12.8.15.4 Strategic Initiatives
- 12.8.16 Sero AS.
- 12.8.16.1 Company Overview
- 12.8.16.2 Financial Performance
- 12.8.16.3 Product Benchmarking
- 12.8.16.4 Strategic Initiatives
- 12.8.17 Sun Diagnostics, LLC
- 12.8.17.1 Company Overview
- 12.8.17.2 Financial Performance
- 12.8.17.3 Product Benchmarking
- 12.8.17.4 Strategic Initiatives
- 12.8.18 Ortho Clinical Diagnostics, Inc.
- 12.8.18.1 Company Overview
- 12.8.18.2 Financial Performance
- 12.8.18.3 Product Benchmarking
- 12.8.18.4 Strategic Initiatives
- 12.8.19 Randox Laboratories Ltd
- 12.8.19.1 Company Overview
- 12.8.19.2 Financial Performance
- 12.8.19.3 Product Benchmarking
- 12.8.19.4 Strategic Initiatives
- 12.8.20 Helena Laboratories Corporation
- 12.8.20.1 Company Overview
- 12.8.20.2 Financial Performance
- 12.8.20.3 Product Benchmarking
- 12.8.20.4 Strategic Initiatives
- 12.8.21 SeraCare Life Sciences, Inc.
- 12.8.21.1 Company Overview
- 12.8.21.2 Financial Performance
- 12.8.21.3 Product Benchmarking
- 12.8.21.4 Strategic Initiatives
- 12.8.22 Technopath Clinical Diagnostics
- 12.8.22.1 Company Overview
- 12.8.22.2 Financial Performance
- 12.8.22.3 Product Benchmarking
- 12.8.22.4 Strategic Initiatives
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.